Provided by Tiger Trade Technology Pte. Ltd.

Tango Therapeutics Inc.

22.84
-0.5000-2.14%
Post-market: 22.840.0034+0.01%16:20 EDT
Volume:1.85M
Turnover:42.20M
Market Cap:3.86B
PE:-27.19
High:23.50
Open:23.28
Low:22.61
Close:23.34
52wk High:34.39
52wk Low:6.25
Shares:169.00M
Float Shares:142.96M
Volume Ratio:0.80
T/O Rate:1.29%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8400
EPS(LYR):-0.8746
ROE:-21.34%
ROA:-12.99%
PB:3.77
PE(LYR):-26.12

Loading ...

Tango Therapeutics President, R&D Crystal Adam disposes of USD 618,289 in common shares

Reuters
·
Jun 04

Stifel Nicolaus Sticks to Its Buy Rating for Tango Therapeutics (TNGX)

TIPRANKS
·
May 18

Assessing Tango Therapeutics (TNGX) Valuation After Trial Progress And Leadership Changes

Simply Wall St.
·
May 16

Tango Therapeutics falls -14.9%

TIPRANKS
·
May 15

Stock Track | Tango Therapeutics Plummets 10.11% Intraday Following Analyst Rating Downgrade

Stock Track
·
May 15

Tango Therapeutics Inc : Mizuho Raises Target Price to $30 From $20

THOMSON REUTERS
·
May 15

Stock Track | Tango Therapeutics Plunges 9.73% in Pre-Market on Analyst Downgrades

Stock Track
·
May 15

U.S. RESEARCH ROUNDUP- Applied Materials, NVIDIA, Thermo Fisher Scientific

Reuters
·
May 15

Stock Track | Tango Therapeutics Plummets 10.82% Intraday Following Jefferies Downgrade to Hold

Stock Track
·
May 15

Stock Track | Tango Therapeutics Plunges 6.7% in Pre-market Following Jefferies Downgrade to Hold

Stock Track
·
May 14

Stifel Nicolaus Sticks to Their Buy Rating for Tango Therapeutics (TNGX)

TIPRANKS
·
May 14

Tango Therapeutics Inc : Jefferies Cuts to Hold From Buy; Raises Target Price to $27 From $18

THOMSON REUTERS
·
May 14

Tango Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
May 14

Tango Therapeutics Q1 FY26 net loss widens to $45.51 million

Reuters
·
May 14

Tango Therapeutics Q1 EPS USD -0.32

THOMSON REUTERS
·
May 14

Tango Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Highlights

GlobeNewswire
·
May 14

Tango Therapeutics Inc expected to post a loss of 31 cents a share - Earnings Preview

Reuters
·
May 09

Tango Therapeutics Inc - Daniella Beckman to Step Down as CFO Effective April 15, 2026 - SEC Filing

THOMSON REUTERS
·
May 08

Tango Therapeutics CFO Daniella Beckman steps down effective April 15

Reuters
·
May 08

Tango Therapeutics President R&D Crystal Adam sells USD 572,610 common shares

Reuters
·
May 06